|

 |
 |
Management
of the Hospitalized Patient With Sleep Disordered
Breathing
|
 |
|
Dr. Abdullah Alsaeedi,
MD, FRCPC
Respiratory & Sleep Medicine,
Division of Internal Medicine,
Aljahra Hospital, Kuwait
Dr. Mohammed Albader
MD, FRCPC
Respiratory Medicine, Alrashed Allergy
Centre, Kuwait
Dr. A. Alsaeedi. PO
BOX 169, Aljahra 01003, Kuwait.
Email: alsaeedi44@hotmail.com
|
Sleep disordered
breathing (SDB) frequently comes to medical
attention for the first time when patients
are hospitalized for diagnosis and treatment
of an associated condition (e.g., poorly
controlled hypertension, myocardial infarction,
congestive heart failure, stroke, or problems
related to management of diabetes mellitus).
Diagnosis of SDB is generally performed
in a specialized facility, which is often
inconvenient and expensive for the hospitalized
patient. Expectant peri-operative management
of patients with sleep apnea is critical,
particularly if they are previously undiagnosed.
An ideal diagnostic strategy for these patients
has not been defined. Continuous positive
airway pressure (CPAP) is the mainstay of
treatment of patients with sleep apnea.
Unfortunately, it is often difficult for
very ill patients to tolerate CPAP, unless
it is administered with a high level of
expertise.
Sleep disordered breathing
(SDB), particularly obstructive sleep apnea
(OSA), is a prevalent condition that is
often undiagnosed. The development of obstructive
apnea events is related to upper-airway
anatomy and function. The relative contribution
of these factors may vary widely. Obstruction
most often occurs when upper-airway muscle
tone is decreased relative to wakefulness.
The upper airway collapses, with inspiration
leading to obstructed breathing. The patient
restores breathing at the expense of sleep
continuity only to enter another phase of
obstruction as sleep returns. This repetitive
cycle of disordered breathing often produces
episodic hypoxemia, increased stimulation
of the sympathetic nervous system, and poor
sleep quality.[1] Other sleep-related respiratory
disturbances include Cheyne-Stokes breathing
and central sleep apnea (CSA), characterized
by oscillation or absence of respiratory
effort.[2]
Population studies of middle-aged
adults indicate that approximately 9% of
women and 24% of men have SDB.[3] It has
been estimated that 5% of all adults in
Western countries have undiagnosed sleep
apnea.[4] Even a relatively mild degree
of OSA may be associated with adverse consequences
including excess mortality,[5, 6] coronary
artery disease manifestation,[7] stroke,[8]
insulin resistance,[9] and increased risk
of automobile accidents.[10] Studies have
concluded that subjects with SDB are more
likely to use health care resources and
services before diagnosis.[11, 12] Therefore,
incidental hospitalization of a patient
with OSA may present a valuable opportunity
for diagnosis. It also represents a potential
challenge in management.
The impact of SDB on medical
and surgical patients has not been rigorously
investigated because it is largely speculative.
Episodic hypoxemia and poor sleep quality
may compromise recovery from medical illnesses.
Furthermore, it is reasonable to assume
that patients whose upper-airway patency
is compromised during sleep are also at
risk following administration of analgesia
and anesthesia. This paper will briefly
review data by which we may estimate the
likelihood that OSA is present in association
with commonly encountered medical conditions.
Some reasonable precautions to avoid complications
of SDB in medical and surgical patients
will be presented. Finally, the inherent
difficulties of diagnosis and treatment
of a sick patient not previously known to
have SDB will be discussed.
Obstructive Sleep Apnea
in Hospitalized Patients
It has been suspected for many years that
OSA is causally linked to cardiovascular
complications. Until recently, investigations,
purported to demonstrate this association,
have been criticized for not meeting currently
accepted standards of evidence.[13] The
strengths and weaknesses of more recent
studies have been discussed elsewhere.[14-17]
It is clear, however, that groups of patients
undergoing treatment for a variety of conditions
demonstrate an increase in the occurrence
of daytime sleepiness, snoring, and OSA.
These studies are relevant because they
highlight the likelihood that SDB will be
encountered in hospitalized patients.
Hypertension
The relation between hypertension and OSA
is now well established.[5, 18, 19] Even
mild SDB is associated with an increased
risk of cardiovascular disease.[20] The
prevalence of OSA in hypertensive patients
is not known. However, patients with hypertension
that is difficult to control are particularly
likely to have OSA.[21] Logan et al.[22]
found that 83% of patients with drug-resistant
hypertension had apnea/hypopnea indices
(AHI) >/= ten events per hour. Effective
treatment of patients with sleep apnea may
result in decreases in systolic and diastolic
blood pressure.[23-25]
Coronary Artery Disease
and Myocardial Infarction
Numerous studies have suggested that a high
proportion of patients with coronary artery
disease (CAD) have OSA. Using a non-laboratory
based overnight recording device, Schäfer
et al.[26] found a 30.5% prevalence of OSA
(defined as an AHI >/= 10) in patients
with angiographically proven coronary artery
disease versus 19.7% in controls. Other
studies have reported prevalence of OSA
in patients with CAD ranging from 14-65%.[27-30]
Peker et al.[31] highlight the potential
importance of OSA in patients with CAD and
conclude that the presence of OSA was independently
associated with an increased risk of cardiovascular
mortality. Death occurred in 37.5% of patients
with OSA over a 5-year follow-up period
compared with 9.3% in patients without OSA.
Stroke
There is a high prevalence of SDB after
stroke. Dyken et al.[33] found OSA on polysomnography
in 77% of men and 64% of woman with recent
strokes compared with 23% and 14%, respectively,
in controls. Studying patients with stroke
and transient ischemic attacks, Bassetti
and Aldrich[34]] found an AHI >/= 10
in 62.5% of patients and only 12.5% of control
subjects. Obstructive and central sleep
apneas are common occurrences immediately
following first time stroke.[35] Good et
al.[36] reported 40% of stroke patients
admitted to a rehabilitation unit demonstrated
OSA identified by oximetry and confirmed
with polysomnography. Parra et al.[37] reported
that 71% of first time TIA and stroke patients
had AHI >/= 10 in the acute phase. Wessendorf,
Teschler, and Wang[38] reported prevalence
of 61%, 44%, 32%, and 22% based on AHI cutoff
points of 5, 10, 15, and 20 respectively.
Good et al.[36] found functional outcome
to be significantly worse in stroke patients
with SDB. By contrast, Parra et al.[37]
and Iranzo et al.[39] did not find a significant
effect of OSA on functional outcome.
Recently, Wessendorf et al.[40]
and Sandberg et al.[41] conducted treatment
trials with CPAP in stroke patients. Improvements
in depressive symptoms, sense of well-being,
and nocturnal blood pressure were reported.
Sandberg et al.[41] emphasized that compliance
with CPAP is a problem for stroke patients
especially in the presence of delirium and
cognitive impairment.
Diabetes
Mellitus
As a result of obesity or as an independent
consequence of SDB, OSA has recently been
linked to type 2 diabetes. Two recent studies
have examined the relation between OSA and
insulin resistance. Punjabi et al.[42] found
that an AHI >/= 5 demonstrated an independent
relation to glucose intolerance and insulin
resistance despite controlling for body
mass index (BMI) and AHI. Ip et al.[43]
confirmed this observation.
Al-Delaimy et al.[44] looked
at the relation between snoring and diabetes
in the Nurses Health Study cohort.
After adjusting for age and BMI, they found
that, over a 10-year follow-up period, occasional
and regular snorers demonstrated a significant
increase in diagnosis with type 2 diabetes.
|
|
Gastroesophageal Reflux
Disease
Many patients with OSA will experience painful
heartburn and gastroesophageal reflux. The
prevalence of this association has not been
fully described.[45] Anecdotal experience
suggests that patients with GERD frequently
experience an improvement of symptoms with
successful use of CPAP.[46]
Congestive Heart Failure
Up to 50% of patients with stable, medically
treated heart failure will show signs of
SDB, most often in the form of central sleep
apnea.[47] Mortality in congestive heart
failure patients with untreated SDB is much
higher than in those with heart failure
alone.[48] Treatment with CPAP has been
shown to significantly decrease mortality
in patients with end-stage heart failure
and SDB.[49] A study by Sin et al.[50] showed
that patients with central sleep apnea waiting
for heart transplant treated with CPAP had
a significant increase in transplant-free
survival.
Effects of Analgesia and
Anesthesia on Patients With Sleep Apnea
Several recent reviews have highlighted
the importance of OSA as a potential risk
for complications related to anesthesia
and analgesia after surgery.[51-53] However,
the magnitude of this problem has not been
well defined.[54] One uncontrolled study
found that 17% of patients with OSA receiving
general anesthesia, developed complications
related to airway management.[55] Many of
the factors responsible for upper-airway
compromise in sleep are also present with
anesthesia.[56] Anesthetic agents and narcotic
medications increase the tendency for the
upper airway to collapse. Furthermore, these
agents impair the arousal response that
terminates an episode of apnea, thereby
increasing apnea severity.[57] Anesthetic
agents alter several characteristics of
sleep but these effects are difficult to
separate from the effects of pain, pain
management, and sleep deprivation in the
hospital.[58, 59] As pain decreases after
surgery and the effects of sleep deprivation
accumulate, many patients experience a rebound
of REM sleep during which sleep apnea is
often most severe.[60, 61] The relation
between severity of apnea and risk of sedation
is ill defined. Gupta et al.[62] reported
that even mild OSA represented a risk for
orthopedic patients.
Prevention of Complications
During Surgery for Patients With Obstructive
Sleep Apnea
The greatest problem facing the anesthesiologist
attempting to minimize complications related
to sleep apnea is the fact that many, if
not most, patients with OSA are undiagnosed.[4]
Often, the anesthesiologists contact
with the patient before surgery is brief.
Patients with known OSA should be advised
to notify the surgeon and anesthesia personnel
of that diagnosis. It is reasonable to consider
postponing elective surgery for patients
with historical and physical examination
findings suggestive of sleep apnea until
diagnosis and treatment can be accomplished.
A high level of expectant monitoring is
necessary for patients who must proceed
with urgent or non-elective surgery. Of
particular concern are patients who have
previously undergone surgical therapy for
sleep apnea because there is a significant
tendency for relapse a few years after treatment.[63]
Preparation Before Surgery
Once it is established or suspected that
the patient has sleep apnea, a number of
precautions are essential. The hallmark
of safety administering anesthesia to patients
with OSA is the concept that the patients
airway must be controlled at all times.
Unsupervised sedation before surgery should
be avoided. The patients airway should
be secured with either an oropharyngeal
or nasopharyngeal airway during induction.
A 3-5 minute period of pre-oxygenation may
provide a brief cushion of safety.
Anesthesia Management
A system for intubation over a fiberoptic
scope should be available and used if there
is any doubt regarding ability to intubate
the patient. Paralyzing agents, even short-acting
agents, should be used with caution.[64]
A surgeon should be available to perform
an emergency tracheotomy if necessary.
Problems with intubation may
be avoided by use of local or regional anesthesia.
However, sedation may be more dangerous
than intubation with airway control in these
patients. Extubation is perhaps the greatest
danger for patients with sleep apnea. The
patient must be sufficiently awake to protect
his airway before extubation can be safely
accomplished. If the possibility of the
presence of sleep apnea has been overlooked,
this may be the time when unexpected difficulties
develop.
Management After Surgery
Patient-administered pain control systems
should be used with caution. Orders for
narcotic analgesics or sedative medications
should not be written on an as needed
basis. The patient using CPAP therapy at
home should be allowed to bring his own
equipment to the hospital. Close observation
remains important because his ability to
use this equipment unaided may be impaired
after surgery. Also, it is possible that
the effects of surgery and analgesia may
alter the appropriate CPAP settings. If
the patient has not used CPAP previously,
it may be necessary to initiate this therapy
empirically.
Diagnosis of Sleep Disordered
Breathing
Diagnosis of SDB is most often based on
a polysomnography performed in a specialized
facility.[65] For polysomnography to be
effective, the patient must be able to sleep
for extended periods of time. The sleep-disrupting
environment of the hospital is well recognized.
There is likely to be significant impact
on sleep quality and continuity resulting
from pain, anxiety, as well as patient-monitoring
procedures, medication administration, routine
nursing care, and hospital noise. Significant
OSA can occur even in the absence of any
suggestive physical findings or history.[66,
67] Limited sleep studies may have some
utility but the role of this technology
has been inconsistently validated. Oximetry
alone is of little value because it is inadvisable
to allow a patient under the stress of acute
illness or surgery to become hypoxemic.
Furthermore, there can be no certainty that
the patients sleep in the hospital
is a valid reflection of sleep at home.
Consequently, it may be necessary to initiate
therapy for presumed sleep apnea on an empiric
basis. It must be emphasized that the diagnosis
must be confirmed when the patient has recuperated
significantly.
Empiric Treatment With
Continuous Positive Airway Pressure
Key features of successful use of CPAP include
effective mask fitting, correct institution
of an optimal pressure level, and adequate
patient education. All of these keys are
potentially compromised in the setting of
care of an acutely ill patient. Patients
clearly should be protected during nocturnal
sleep as well as naps, which may occur anytime
when a patient is hospitalized. Most CPAP
masks are not designed to be worn 24 hours
per day and may produce serious skin breakdown
as well as discomfort. Recently introduced
masks that cover the entire face, such as
the Respironics Total (Respironics, Pittsburgh,
PA) mask, have become popular for non-invasive
ventilation in the critical care unit. It
is surprisingly well tolerated and may represent
a useful option for some patients.
CPAP, or more specifically
bi-level CPAP, is being used increasingly
frequently for noninvasive ventilation.
As a result, most respiratory therapy departments
are familiar with mask ventilation. Unfortunately,
long-term compliance with this therapy is
disappointing.[68, 69] Most patients with
sleep apnea do not require bi-level CPAP.
However, it is very important that patients
being started on CPAP therapy for sleep
apnea begin treatment under the best possible
conditions. Otherwise, they are likely to
discard the treatment when they return home
and even refuse subsequent evaluation and
management. Careful monitoring and support
of patients treated with CPAP for OSA has
been shown to improve compliance.[70, 71]
Some attempt at titration of pressure to
identify optimal CPAP settings should be
performed. There may be a role for automatically
adjusting CPAP devices. The potential benefits
and limitations of this technology have
recently been reviewed in detail.[72] It
should be emphasised that auto-CPAP is not
an adequate substitute for polysomnography
testing when the patient has stabilized.
Controlled studies of different CPAP modalities
during the transition from hospital to home
care are needed.
OSA is commonly encountered
in patients hospitalized for conditions
that may or may not be directly associated
to SDB. This fact represents an opportunity
for diagnosis and a challenge for management.
Unfortunately, medical education has historically
devoted minimal time to this aspect of human
health and diseases.[73] Careful attention
to reports of excessive sleepiness or other
features of sleep apnea in the patients
history must be taken seriously. Physical
findings that predispose to airway compromise
should be noted. Major complications of
surgery may well be prevented if health
care providers exercise due caution regarding
SDB. Acute medical or surgical illness,
particularly if the level of central nervous
system function is affected by the illness
or its treatment, may amplify SDB manifestations.
The ideal approach to diagnosis
and therapy under these circumstances is
unknown. The relation between OSA in the
hospital setting and persistent OSA at home
after the dust has settled is
often unpredictable and may vary greatly
depending on specific circumstances. For
example, episodic hypoxemia in a hospitalized
patient receiving opiates may not be a valid
predictor of the presence or severity of
sleep apnea after recuperation. In most
cases, a presumptive diagnosis of SDB made
in a hospitalized patient should be corroborated
by a standard polysomnography evaluation
when the patient is stable. Empiric use
of self-adjusting or bi-level CPAP may be
helpful in some circumstances. An unfavorable
initial experience with CPAP can complicate
long-term compliance. Therefore, positive
airway pressure therapy must be applied
with a high level of expertise in sick patients
who are naive regarding this treatment.
|
|
.
|
|
1. |
Kuna
S, Remmers JE: Anatomy and physiology
of upper airway obstruction. In Principles
and Practice of Sleep Medicine, edn
3. Edited by Kryger MH, Roth T, Dement
WC. Philadelphia: W.B. Saunders;2000:840-858 |
2. |
White DP: Central sleep apnea. In Principles
and Practice of Sleep Medicine, edn
3. Edited by Kryger MH, Roth T, Dement
WC. Philadelphia: W.B. Saunders;2000:827-839.
|
3. |
Young
T, Palta M, Dempsey J, et al.: The occurrence
of sleep-disordered breathing among
middle-aged Adults. N Engl J Med 1993,
328:1230-1235. |
4. |
Young
T, Evans L, Finn L, et al.: Estimation
of the clinically diagnosed proportion
of sleep apnea syndrome in middle aged
men and women. Sleep 1997, 20:705-706.
|
5. |
He
J, Kryger MH, Zorick FJ, et al.: Mortality
and apnea index in obstructive sleep
apnea: experience in 385 male patients.
Chest 1988, 94:9-14. |
6. |
Coy
TV, Dimsdale JE, Ancoli-Israel , et
al.: The role of sleep-disordered breathing
in essential hypertension. Chest 1996,
108:890-895. |
7. |
Hung
J, Whitford EG, Parsons RW, et al.:
Association of sleep apnoea with myocardial
infarction in men. Lancet 1990, 336:261-264.
|
8. |
Palomaki H, Partinen M, Erkinjuntti
T, et al.: Snoring, sleep apnea syndrome,
and stroke. Neurology 1992, 42:75-81.
|
9. |
Strohl
KP: Invited commentary: to sleep, perchance
to discover. Am J Epidemiol 2002, 155:394-395.
|
10. |
Aldrich
MS: Automobile accidents in patients
with sleep disorders. Sleep 1989, 12:487-494.
|
11. |
Kapur
VK, Redline S, Nieto FJ, et al.: The
relationship between chronically disrupted
sleep and healthcare use. Sleep 2002,
25:289-296. |
12. |
Smith
R, Ronald J, Delaive K, et al.: What
are obstructive sleep apnea patients
being treated for prior to this diagnosis?
Chest 2002, 121:164-172. |
13. |
Wright J, Johns R, Watt I, et al.: Health
effects of obstructive sleep apnoea
and the effectiveness of continuous
positive airways pressure: a systematic
review of the research evidence. Br
Med J 1997, 314:851-860. |
14. |
Young
T, Peppard PE, Gottlieb DJ: Epidemiology
of obstructive sleep apnea. Am J Resp
Crit Care Med 2002, 165:1217-1239. |
15. |
Lindberg
E, Gislason T: Epidemiology of sleep-related
obstructive breathing. Sleep Med Rev
2000, 4:411-433. |
16. |
Lanfranchi
P, Somers VK: Obstructive sleep apnea
and vascular disease. Respir Res 2001,
2:315-319. |
17. |
Pankow W, Lies A, Lohmann FW: Sleep-disordered
breathing and hypertension. N Engl J
Med 2000, 343:966. |
18. |
Bixler
EO, Vgontzas AN, Lin HM, et al.: Association
of hypertension and sleep-disordered
breathing. Arch Intern Med 2000, 160:2289-2295.
|
19. |
Young
T, Peppard P, Palta M, et al.: Population-based
study of sleep-disordered breathing
as a risk factor for hypertension. Arch
Intern Med 1997, 157:1746-1752. |
20. |
Nieto
FJ, Young TB, Lind BK, et al.: Association
of sleep-disordered breathing, sleep
apnea, and hypertension in a large community-based
study. JAMA 2000, 283:1829-1836. |
21. |
Lavie
P, Hoffstein V: Sleep apnea syndrome:
a possible contributing factor to resistant
hypertension. Sleep 2001, 24:721-725.
|
22. |
Logan
AG, Perlikowski SM, Mente A, et al.:
High prevalence of unrecognized sleep
apnea in drug-resistant hypertension.
J Hypertens 2001, 19:2271-2277. |
23. |
Mayer
J, Becker H, Brandenburg U, et al.:
Blood pressure and sleep apnea: results
of long-term nasal continuous positive
airway pressure therapy. Cardiology
1991, 79:84-92. |
24. |
Suzuki M, Otsuka K, Guilleminault C:
Long-term nasal continuous positive
airway pressure administration can normalize
hypertension in obstructive sleep apnea
patients. Sleep 1993, 16:545-549. |
25. |
Wilcox I, Grunstein RR, Hedner JA, et
al.: Effect of nasal continuous positive
airway pressure during sleep on 24-hour
blood pressure in obstructive sleep
apnea. Sleep 1993, 16:539-544. |
26. |
Schäfer
H, Koehler U, Ewig S, et al.: Obstructive
sleep apnea as a risk marker in coronary
artery disease. Cardiology 1999, 92:79-84.
|
27. |
Mooe
T, Rabben T, Franklin KA, et al.: Sleep-disordered
breathing in men with coronary artery
disease. Chest 1996, 109:659-663. |
28. |
Mooe
T, Rabben T, Wiklund U, et al.: Sleep-disordered
breathing in women: occurrence and association
with coronary artery disease. Am J Med
1996, 101:251-256. |
29. |
Hung
J, Whitford EG, Parsons RW, et al.:
Association of sleep apnoea with myocardial
infarction in men. Lancet 1990, 336:261-264.
|
30. |
De
Olazabal JR, Miller MJ, Cook WR, et
al.: Disordered breathing and hypoxia
during sleep in coronary artery disease.
Chest 1982, 82:548-552. |
31. |
Peker
Y, Hedner J, Kraiczi H, et al.: Respiratory
disturbance index: an independent predictor
of mortality in coronary artery disease.
Am J Respir Crit Care Med 2000, 162:81-86.
|
32. |
Mohsenin
V: Sleep-related breathing disorders
and risk of stroke. Stroke 2001, 32:1271-1278.
|
33. |
Dyken
ME, Somers VK, Yamada T, et al.: Investigating
the relationship between stroke and
obstructive sleep apnoea. Stroke 1996,
27:401-407. |
34. |
Bassetti
C, Aldrich MS: Sleep apnoea in acute
cerebrovascular disease; final report
on 128 patients. Sleep 1999, 22:217-223.
|
35. |
Bassetti
C, Aldrich MS, Quint D: Sleep-disordered
breathing in patients with acute supra-
and infratentorial strokes. A prospective
study of 39 patients. Stroke 1997, 28:1765-1772.
|
36. |
Good
DC, Henkle JG, Gelber D, et al.: Sleep-disordered
breathing and poor functional outcome
after stroke. Stroke 1996, 27:252-259.
|
37. |
Parra
O, Arboix A, Bechich S, et al.: Time
course of sleep-related breathing disorders
in first-ever stroke or transient ischemic
attack. Am J Respir Crit Care Med. 2000,
161:375-380. |
38. |
Wessendorf
TE, Teschler H, Wang Y-M: Sleep-disordered
breathing among patients with first-ever
stroke. J Neurol 2000, 247:41-47. |
|
|
39. |
Iranzo
A, Santamaria J, Berenguer J, et al.:
Prevalence and clinical importance of
sleep apnea in the first night after
cerebral infarction. Neurology 2002,
58:911-916. |
40. |
Wessendorf
TE, Wang Y-M, Thilmann AF, et al.: Treatment
of obstructive sleep apnoea with nasal
continuous positive pressure in stroke.
Eur Resp J 2001, 18:623-629. |
41. |
Sandberg
O, Franklin KA, Bucht G, et al.: Nasal
continuous positive airway pressure
in stroke patients with sleep apnoea:
a randomized treatment study. Eur Resp
J 2001, 18:630-634. |
42. |
Punjabi
NM, Sorkin JD, Katzel LI, et al.: Sleep-disordered
breathing and insulin resistance in
middle-aged and overweight men. Am J
Respir Crit Care Med 2002, 165:677-682.
|
43. |
Ip
MSM, Lam B, Ng MM, et al.: Obstructive
sleep apnea is independently associated
with insulin resistance. Am J Respir
Crit Care Med 2002, 165:670-676. |
44. |
Al-Delaimy
WK, Manson JE, Willett WC, et al.: Snoring
as a risk factor for type II diabetes
mellitus: a prospective study. Am J
Epidemiol 2002, 155:387-393. |
45. |
Ing
AJ, Ngu MC, Breslin AB: Obstructive
sleep apnea and gastroesophageal reflux.
Am J Med 2000, 108 (suppl 4a): 120S-125S.
|
46. |
Kerr
P, Shoenut JP, Millar T, et al.: Nasal
CPAP reduces gastroesophageal reflux
in obstructive sleep apnea syndrome.
Chest 1992, 101:1539-1544. |
47. |
Javaheri
S, Parker TJ, Liming JD, et al.: Sleep
apnea in 81 ambulatory male patients
with stable heart failure. Types and
their prevalences, consequences, and
presentations. Circulation 1998, 97:2154-2159.
|
48. |
Lanfranchi
PA, Braghiroli A, Bosimini E, et al.:
Prognostic value of nocturnal Cheyne-Stokes
respiration in chronic heart failure.
Circulation 1999, 99:1435-1440. |
49. |
Willson
GN, Wilcox I, Piper AJ, et al.: Noninvasive
pressure preset ventilation for the
treatment of Cheyne-Stokes respiration
during sleep. Eur Respir J 2001, 17:1250-1257.
|
50. |
Sin
DD, Logan AG, Fitzgerald FS, et al.:
Effects of continuous positive airway
pressure on cardiovascular outcomes
in heart failure patients with and without
Cheyne-Stokes respiration. Circulation
2000, 102:61-66. |
51. |
Benumof
JL: Obstructive sleep apnea in the adult
obese patient: implications for airway
management. J Clin Anesth 2001, 13:144-156.
|
52. |
Loadsman
JA, Hillman DR: Anesthesia and sleep
apnoea. Br J Anaesth 2001, 86:254-266.
|
53. |
Boushra
NN: Anaesthetic management of obstructive
sleep apnea patients. Can J Anaesth
1996, 43:599-616. |
54. |
Cullen
DJ: Obstructive sleep apnea and postoperative
analgesia - a potentially dangerous
combination. J Clin Anesth 2001, 13:83-85.
|
55. |
Erman
MK, Loube DI: Perioperative complications
in obstructive sleep apnea patients.
Sleep Breathing 1997, 1:3-10. |
56. |
Eastwood
PR, Szollosi I, Platt PR, et al.: Comparison
of upper airway collapse during general
anesthesia and sleep. Lancet 2002, 359:1207-1209.
|
57. |
Robinson
RW, Zwillich CW, Bixler EO, et al.:
Effects of oral narcotics on sleep-disordered
breathing in healthy adults. Chest 1987,
91:197-203. |
58. |
Aurell
J, Elmqvist D: Sleep in the surgical
intensive care unit: continuous polygraphic
recording of nine patients receiving
postoperative care. BMJ Clin Res Ed
1985, 290:1029-1032. |
59. |
Rosenberg
J, Rosenberg-Adamsen S, Kehlet H: Post-operative
sleep disturbances: causes, factors
and effects on outcome. Eur J Anaesthesiol
1995, 10 (suppl): 28-30. |
60. |
Rosenberg
J, Rasmussen GI, Wojdemann KR, et al.:
Ventilatory pattern and associated episodic
hypoxaemia in the late postoperative
period in the general surgical ward.
Anaesthesia 1999, 54:323-328. |
61. |
Knill
RL, Moote CA, Skinner MI, et al.: Anesthesia
with abdominal surgery leads to intense
REM sleep during the first postoperative
week. Anesthesiology 1990, 73:52-61.
|
62. |
Gupta
R, Parvizi J, Hanssen A, et al.: Postoperative
complications in patients with obstructive
sleep apnea undergoing hip or knee replacement:
a case-control study. Mayo Clin Proc
2001, 76:897-905. |
63. |
Levin
BC, Becker GD: UPPP for snoring: long-term
results. Laryngoscope 1994, 104:1150-1152.
|
64. |
Benumof
JL, Dagg R, Benumof R: Critical hemoglobin
desaturation will occur before return
to an unparalyzed state following 1
mg/kg intravenous succinylcholine. Anesthesiology
1997, 87:979-982. |
65. |
Chesson
Jr , AL Ferber RA, Fry JM, et al.: The
indications for polysomnography and
related procedures. Sleep 1997, 20:423-487.
|
66. |
Hoffstein
V, Szalai JP: Predictive value of clinical
features in diagnosing obstructive sleep
apnea. Sleep 1993, 16:118-122. |
67. |
Schäfer
H, Ewig S, Hasper E, et al.: Predictive
diagnostic value of clinical assessment
and nonlaboratory monitoring system
recordings in patients with symptoms
suggestive of obstructive sleep apnea
syndrome. Respiration 1997, 64:194-199.
|
68. |
Sinuff
T, Cook D, Randall J, et al.: Noninvasive
positive-pressure ventilation: a utilization
review in a teaching hospital. CMAJ
2000, 163:969-973. |
69. |
Criner
GJ, Brennan K, Travaline JM, et al.:
Efficacy and compliance with noninvasive
positive pressure ventilation in patients
with chronic respiratory failure. Chest
1999, 116:667-675. |
70. |
Chervin
RD, Theut S, Bassetti C, et al.: Compliance
with nasal CPAP can be improved by simple
interventions. Sleep 1997, 20:284-289. |
71. |
Hoy CJ, Vennelle M, Kingshott RN, et
al.: Can intensive support improve continuous
positive airway pressure use in patients
with the sleep apnea/hypopnea syndrome?
Am J Respir Crit Care Med 1999, 159:1096-1100.
|
72. |
Berry
RB, Parish JM, Hartse KM: The use of
auto-titrating continuous positive airway
pressure for treatment of adult obstructive
sleep apnea. An American Academy of
Sleep Medicine review. Sleep 2002, 25:148-173.
|
73. |
Rosen
R, Mahowald M, Chesson A, et al.: The
taskforce 2000 survey on medical education
in sleep and sleep disorders. Sleep
1998, 21:235-238.
|
|
|
|
|
|
|